{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:07:40Z","timestamp":1789952860460,"version":"4.0.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/cmr.0b013e32834acc37","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:31:23Z","timestamp":1317742283000},"page":"483-490","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma"],"prefix":"10.1097","volume":"21","author":[{"given":"Zheng-Sheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Wang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Jing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","first-page":"13","article-title":"Your patient with melanoma: staging, prognosis, and treatment.","volume":"23","author":"Rubin","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bcp.2005.12.017","article-title":"JAKSTAT signal transduction: regulators and implication in hematological malignancies.","volume":"71","author":"Valentino","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"R5-3-20210129","first-page":"945","article-title":"Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.","volume":"8","author":"Buettner","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis.","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer - new molecular targets come of age.","volume":"4","author":"Yu","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1207606","article-title":"STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.","volume":"23","author":"Kanda","year":"2004","journal-title":"Oncogene"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1600-0463.2006.apm_401.x","article-title":"Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.","volume":"114","author":"Choi","year":"2006","journal-title":"APMIS"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jcp.2006.036970","article-title":"Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.","volume":"60","author":"Yang","year":"2007","journal-title":"J Clin Pathol"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.3748\/wjg.v16.i42.5380","article-title":"STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.","volume":"16","author":"Deng","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/cncr.24748","article-title":"Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.","volume":"116","author":"Kim","year":"2010","journal-title":"Cancer"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1158\/0008-5472.CAN-05-2674","article-title":"Activation of stat3 in human melanoma promotes brain metastasis.","volume":"66","author":"Xie","year":"2006","journal-title":"Cancer Res"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/107327480801500302","article-title":"Activated stat-3 in melanoma.","volume":"15","author":"Messina","year":"2008","journal-title":"Cancer Control"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/PL00000801","article-title":"The suppressors of cytokine signalling (SOCS).","volume":"58","author":"Kile","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.resp.2005.07.001","article-title":"SOCS3 was induced by hypoxia and suppressed STAT3 phosphorylation in pulmonary arterial smooth muscle cells.","volume":"152","author":"Bai","year":"2006","journal-title":"Respir Physiol Neurobiol"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0092-8674(02)00701-8","article-title":"Cytokine signaling in 2002: new surprises in the JakStat pathway.","volume":"109","author":"OShea","year":"2002","journal-title":"Cell"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/ijc.23337","article-title":"Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.","volume":"122","author":"Wu","year":"2008","journal-title":"Int J Cancer"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/gut.2009.184176","article-title":"Disease-related expression of the IL6STAT3SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.","volume":"59","author":"Li","year":"2010","journal-title":"Gut"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-005-1580-1","article-title":"Targeting STAT3 affects melanoma on multiple fronts.","volume":"24","author":"Kortylewski","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"R23-3-20210129","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1038\/sj.onc.1208435","article-title":"RKIP downregulates B-Raf kinase activity in melanoma cancer cells.","volume":"24","author":"Park","year":"2005","journal-title":"Oncogene"},{"key":"R24-3-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.cmr.0000215035.38436.87","article-title":"BRAF somatic mutations in melanoma and melanocytic naevi.","volume":"16","author":"Thomas","year":"2005","journal-title":"Melanoma Res"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.3800750","article-title":"Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.","volume":"20","author":"Zhuang","year":"2007","journal-title":"Mod Pathol"},{"key":"R26-3-20210129","first-page":"1389","article-title":"Biological activity and clinical implications of the matrix metalloproteinases.","volume":"28","author":"Rydlova","year":"2008","journal-title":"Anticancer Res"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","article-title":"Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.","volume":"27","author":"Roy","year":"2009","journal-title":"J Clin Oncol"},{"key":"R28-3-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biochi.2005.01.013","article-title":"Role of matrix metalloproteinases in melanoma cell invasion.","volume":"87","author":"Hofmann","year":"2005","journal-title":"Biochimie"},{"key":"R29-3-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-010-0273-y","article-title":"Inhibition of the JAK-2STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.","volume":"101","author":"Senft","year":"2011","journal-title":"J Neurooncol"},{"key":"R30-3-20210129","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1158\/0008-5472.CAN-07-0858","article-title":"Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.","volume":"67","author":"Landen","year":"2007","journal-title":"Cancer Res"},{"key":"R31-3-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1593\/neo.07971","article-title":"Inhibition of JAK1, 2STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells.","volume":"10","author":"Xiong","year":"2008","journal-title":"Neoplasia"},{"key":"R32-3-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response.","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"R33-3-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/ar1741","article-title":"Negative regulation of cytokine signaling and immune responses by SOCS proteins.","volume":"7","author":"Yoshimura","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R34-3-20210129","doi-asserted-by":"crossref","first-page":"14133","DOI":"10.1073\/pnas.2232790100","article-title":"SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.","volume":"100","author":"He","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-3-20210129","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cellbi.2009.06.002","article-title":"Restoration of SOCS3 suppresses human lung adenocarcinoma cell growth by downregulating activation of Erk12, Akt apart from STAT3.","volume":"33","author":"Yu","year":"2009","journal-title":"Cell Biol Int"},{"key":"R36-3-20210129","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1038\/sj.onc.1207787","article-title":"Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.","volume":"23","author":"Sutherland","year":"2004","journal-title":"Oncogene"},{"key":"R37-3-20210129","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00432-010-0819-6","article-title":"Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma.","volume":"136","author":"Ying","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"R38-3-20210129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/00313020802320432","article-title":"SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma.","volume":"40","author":"Yang","year":"2008","journal-title":"Pathology"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.onc.1209993","article-title":"Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.","volume":"26","author":"Evans","year":"2007","journal-title":"Oncogene"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2407-10-142","article-title":"Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.","volume":"10","author":"Lesinski","year":"2010","journal-title":"BMC Cancer"},{"key":"R41-3-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjc.6603849","article-title":"Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.","volume":"97","author":"Fojtova","year":"2007","journal-title":"Br J Cancer"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008390-201112000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:04Z","timestamp":1786047964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008390-201112000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e32834acc37","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}